You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

h101

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Genital Tumors, Female Trial in Xi'an (H101)

Recruiting
  • Genital Neoplasms, Female
  • H101
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi'an Jiao Tong University
Oct 10, 2021

Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • H101
  • +2 more
  • (no location specified)
Apr 11, 2023

Refractory Malignant Ascites Trial in Shanghai (H101, Tislelizumab)

Recruiting
  • Refractory Malignant Ascites
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 2, 2022

Pancreatic Ductal Adenocarcinoma Trial in Shanghai (H101, Tislelizumab, lenvatinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • H101
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 30, 2022

Hepatocellular Carcinoma Trial in Guangzhou (HAIC of FOLFOX, H101, Placebos)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC of FOLFOX
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 19, 2020

Hepatocellular Carcinoma Trial in Chongqing (H101, RFA)

Unknown status
  • Hepatocellular Carcinoma
  • H101
  • RFA
  • Chongqing, Chongqing, China
  • +1 more
Oct 15, 2019